Goater Jeff 4
4 · Surface Oncology, Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Goater Jeff
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2021-02-08$12.50/sh−2,500$31,250→ 262,000 total - Exercise/Conversion
Common Stock
2021-02-08$3.18/sh+2,500$7,950→ 264,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-08−2,500→ 247,000 totalExercise: $3.18Exp: 2030-02-03→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020.
- [F2]This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates.